The cytoplasmic domain (residues 1-446), G domain (1-339), middle domain (340-446), truncated middle domain (1-366), and C-terminal ECFP/EYFP fusions (atlastin1 1-446 followed by a short linker containing amino acid sequence GSTSTG followed by either ECFP or EYFP) of human atlastin-1 were amplified by standard PCR and cloned into a modified pET28a expression plasmid (Novagen) yielding N-terminally hexahistidine-tagged SUMO fusion proteins. The hexahistidine-tagged SUMO-moiety was cleavable using the protease Ulp-1 from S. cerevisiae. The cytoplasmic domain (1-446) used for crystallization of wild-type atlastin was cloned into pET21, yielding Cterminally hexahistidine-tagged protein, which was not cleaved during purification.
in Terrific Broth (TB) media supplemented with 50 µg/ml kanamycin (for expression from pET28) or 100 µg/ml ampicillin (for expression from pET21) at 37°C. At an optical density corresponding to an absorbance of 0.8-1.0 at 600 nm (OD 600 ), the temperature was reduced to 18°C, and protein production was induced with 0.5 mM IPTG. After 16 hours, cells were harvested by centrifugation, resuspended in NiNTA buffer A (25 mM Tris-Cl, pH 8.5, 500 mM NaCl and 20 mM imidazole), and flash-frozen in liquid nitrogen.
After cell lysis by sonication and removal of cell debris by centrifugation, clear lysates were loaded onto NiNTA Superflow (Qiagen) equilibrated in NiNTA buffer A.
The resin was washed with 20 column volumes of NiNTA buffer A, and proteins were eluted three times with 2 column volumes of NiNTA buffer A supplemented with 500 mM imidazole. Proteins were buffer exchanged into desalting buffer (25 mM Tris-HCl, pH 7.5, 400 mM NaCl, 5mM β-mercaptoethanol), with proteins expressed in pET21 constructs immediately subjected to size exclusion chromatography. In the case of proteins expressed with a SUMO moiety, affinity tags were removed by incubation with the yeast protease Ulp-1 at 4°C overnight. Cleaved proteins were collected in the flowthrough during NiNTA affinity chromatography, and were subjected to size exclusion chromatography on a Superdex 200 column (GE Healthcare) equilibrated in gel filtration buffer (25 mM Tris-HCl, pH 7.5, 100 mM NaCl). Proteins were concentrated on a Centricon ultrafiltration device (10 kDa cutoff; Millipore) to a final concentration of approximately 0.5-1 mM. Protein aliquots were flash frozen in liquid nitrogen and stored at -80°C.
Site-directed mutagenesis was carried out using Quikchange (Agilent) following the manufacturer's instructions, followed by validation through DNA sequencing. 1-446 (right panel) was prepared in the absence of nucleotide, and mixed 1:1 with nucleotide-containing buffer (GTPγS; 2 mM) using a stopped-flow apparatus. Experimental details are as stated in Figures 5A and 7 . Time scale of FRET change was monitored over 10 min, and proceeds with similar kinetics to the GTP analog GppNHp (see Figures 5A and 7 for comparison) 
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Dimerization Kinetics
For time-dependent FRET simulations, we propose a simple three-state model based on the available structural information: a monomeric non-FRET state M, an initial dimerization state D 1 , and a possible "relaxed" dimer state D 2 . We assume that the dynamics of nucleotide binding is sufficiently fast as to not significantly contribute to apparent dimerization and FRET behavior and is therefore ignored. Dimerization is modeled by the 2 nd order kinetic equation: can be modeled numerically by discretizing the kinetic equation above:
Where ∆ is the discretized time interval, and the subscript n indicates the n th interval such that = ∆ . The dimer concentration [D] is modeled similarly.
However, with the incorporation of a second possible "relaxed" dimer state, the populations are determined by: 
Where i indicates the i th element of the set of states D 12 and the total time a subpopulation of dimers has spent in transition is = ∆ .
FRET Calculations
FRET can be determined by applying the Förster equation:
Where E is the FRET efficiency, r is the distance between the donor and the acceptor, and R 0 is the Förster distance at which = ! !
. If the fraction of donor molecules is F, and acceptor molecules is (1-F), then the distribution of dimer pairs is given by the binomial distribution:
For any sub-population of dimers, the donor fluorescence (S DONOR ) and the FRET signal (S FRET ) are proportional to the probability of getting a FRET pair:
By assigning a value for r for each state D 1 , D 2 , and a set of r-values for the vector of states D 12 , we can determine the FRET efficiency at each state (E 1 , E 2 , E 12 ). The total signal is given by:
Simulation Parameters
For the GTP-binding dimer simulations, the Förster distance R 0 we used was the calculated value of 47 Å. The value of r for D 1 and D 2 were 30 Å and 50 Å as determined from structural data. We estimate that the equilibrium dissociation constant for dimerization to be better than 1µM, therefore we assumed a dissociation constant
of 500 nM. Assuming a k on of about 0.32 µM -1 s -1 k off was calculated to be 0.16 s -1 . The relaxation rate k 12 was taken to be 0.50 s -1 with a transition time τ 12 of 0.10 s. The time interval ∆ was 0.01 s, which matches the time resolution of the relevant instrumentation. Finally the transition states D 12 were calculated by assuming a uniform transition speed:
For the GppNHp-binding dimer simulations, only the kinetic parameters are assumed to change. Since this system cannot undergo hydrolysis, it is assumed that the relaxation rate constant k 12 is zero and hence does not undergo any transition (i.e. D 12 and D 2 are always zero). We also observed a significantly longer time scale for equilibration of over an order of magnitude. Assuming the equilibrium dissociation constant for dimerization is unchanged, we chose to use a lower k on of 0.006 µM -1 s -1 and thus a calculated k off of 0.003 s -1 .
